Patents by Inventor Seb Caille

Seb Caille has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130345432
    Abstract: The invention provides two process for synthesizing substituted aminothiazolone compounds as inhibitors of 11-?-hydroxy steroid dehydrogenase type 1. The processes allow the stereoselective synthesis of the desired compounds without the use of stoichiometric amounts of chiral catalysts.
    Type: Application
    Filed: July 31, 2013
    Publication date: December 26, 2013
    Applicant: Amgen Inc.
    Inventors: Seb CAILLE, Sheng CUI, Xiang WANG, Margaret FAUL
  • Patent number: 8501954
    Abstract: The invention provides two process for synthesizing substituted aminothiazolone compounds as inhibitors of 11-?-hydroxy steroid dehydrogenase type 1. The processes allow the stereoselective synthesis of the desired compounds without the use of stoichiometric amounts of chiral catalysts.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: August 6, 2013
    Assignee: Amgen Inc.
    Inventors: Seb Caille, Sheng Cui, Xiang Wang, Margaret Faul
  • Publication number: 20110178307
    Abstract: The invention provides two process for synthesizing substituted aminothiazolone compounds as inhibitors of 11-?-hydroxy steroid dehydrogenase type 1. The processes allow the stereoselective synthesis of the desired compounds without the use of stoichiometric amounts of chiral catalysts.
    Type: Application
    Filed: July 28, 2009
    Publication date: July 21, 2011
    Applicant: AMGEN INC.
    Inventors: Seb Caille, Sheng Cui, Xiang Wang, Margaret Faul